Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/22/2026

1. DHR
2. USO
3. NVDA
4. SPY
5. SMCI
6. NOW
7. AMD
8. GM
9. EFX
10. IBM

Go back to Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
(AMEX: IVBIY) Delayed: 44.18 --0 (-0%)
Previous Close $44.18    52 Week High $ 
Open $44.18    52 Week Low $ 
Day High $44.18    P/E N/A 
Day Low $44.18    EPS $ 
Volume 16,639       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.27 -0.11 (7.97%)
Previous Close $1.38    52 Week High $3.85 
Open $1.38    52 Week Low $1.25 
Day High $1.41    P/E N/A 
Day Low $1.25    EPS $-0.28 
Volume 1,990,403